UCB Receives CHMP Positive Opinion On Keppra(R) For Infants And Young Children With Partial-onset Epilepsy
Submitted by MedicalReplies on Monday, 27 July 2009No Comment
UCB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grant marketing authorisation for Keppra® as adjunctive treatment of partial-onset seizures in infants and young children aged one month to under four years.
Here is the original post:
UCB Receives CHMP Positive Opinion On Keppra(R) For Infants And Young Children With Partial-onset Epilepsy
Leave your response!